Financials
- Market Capitalization 13.49 B
- Employee 1 077
- Founded 1994
- CEO Michael M. Morrissey
- Website www.exelixis.com
- Headquarter Delaware, United States
- FIGI BBG000BQ4WF8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
15.68
Rapporto prezzo/fatturato
5.29
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 247.91 USD | -0.58% | -3.29% | -0.84% | +20.88% | 15.36 B USD | ||
| 711 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.60 USD | -2.64% | -5.42% | -4.32% | +34.39% | 14.97 B USD | ||
| 799 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +6.72% | +10.74% | 12.52 B USD | ||
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +5.58% | +26.00% | 12.33 B USD |